G

Genetic Technologies Ltd
D

GENE

0.77430
USD
0.04
(5.35%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
-5
حجم السوق
2,608,473
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BLUE
    0.04000
    (0.51%)
    7.90000 USD
    B
    BMRN
    0.063
    (0.10%)
    62.090 USD
    C
    CRSP
    -0.010
    (-0.02%)
    44.190 USD
    E
    EDIT
    0.07000
    (5.19%)
    1.42000 USD
    N
    NTLA
    0.305
    (2.78%)
    11.295 USD
    REGN
    REGN
    14.51
    (2.13%)
    694.36 USD
    S
    SGMO
    0.03500
    (3.03%)
    1.19000 USD
    VRTX
    VRTX
    11.69
    (2.73%)
    439.78 USD
    المزيد
الأخبار
المقالات

العنوان: Genetic Technologies Ltd

القطاع: Healthcare
الصناعة: Diagnostics & Research
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.